Alliancebernstein L.P. Novo Nordisk A S Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Alliancebernstein L.P. holds 23,490 shares of NVO stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,490

Previous 58,022 59.52%

Holding current value

$2.49 Million

Previous $8.28 Million 66.24%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $4.11 Million - $5.02 Million	-34,532 Reduced 59.52%	23,490 $2.8 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $2.25 Million - $2.7 Million	18,360 Added 46.29%	58,022 $8.28 Million
Q1 2024 May 14, 2024	BUY	$102.11 - $135.92 $517,901 - $689,386	5,072 Added 14.66%	39,662 $5.09 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $538,442 - $646,830	6,134 Added 21.56%	34,590 $3.58 Million
Q3 2023 Nov 14, 2023	SELL	$90.94 - $199.54 $2.76 Million - $6.05 Million	-30,298 Reduced 51.57%	28,456 $2.59 Million
Q2 2023 Aug 15, 2023	BUY	$155.98 - $172.65 $7.11 Million - $7.87 Million	45,589 Added 346.29%	58,754 $9.51 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $73,051 - $87,845	-552 Reduced 4.02%	13,165 $2.1 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $24,714 - $32,614	-241 Reduced 1.73%	13,717 $1.86 Million
Q3 2022 Nov 15, 2022	BUY	$95.28 - $116.93 $23,820 - $29,232	250 Added 1.82%	13,958 $1.39 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $16,415 - $19,367	159 Added 1.17%	13,708 $1.53 Million
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $669,202 - $808,937	-7,188 Reduced 34.66%	13,549 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $3.99 Million - $4.87 Million	-41,627 Reduced 66.75%	20,737 $2.32 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $2.88 Million - $3.64 Million	34,105 Added 120.69%	62,364 $5.99 Million
Q2 2021 Jul 30, 2021	SELL	$67.66 - $84.76 $7.08 Million - $8.87 Million	-104,667 Reduced 78.74%	28,259 $2.37 Million
Q1 2021 May 06, 2021	BUY	$67.06 - $75.82 $2.79 Million - $3.15 Million	41,535 Added 45.45%	132,926 $8.96 Million
Q4 2020 Feb 08, 2021	SELL	$63.89 - $73.8 $7.31 Million - $8.44 Million	-114,358 Reduced 55.58%	91,391 $6.38 Million
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $23.8 Million - $26.2 Million	-373,652 Reduced 64.49%	205,749 $14.3 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $74.1 Million - $86 Million	-1,265,652 Reduced 68.6%	579,401 $37.9 Million
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $16.4 Million - $21.5 Million	-332,166 Reduced 15.26%	1,845,053 $111 Million
Q4 2019 Feb 18, 2020	SELL	$49.86 - $58.26 $4.12 Million - $4.82 Million	-82,664 Reduced 3.66%	2,177,219 $126 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $46.7 Million - $52.5 Million	-983,129 Reduced 30.32%	2,259,883 $117 Million
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $89.8 Million - $101 Million	1,919,351 Added 145.0%	3,243,012 $166 Million
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $1.09 Million - $1.24 Million	-23,610 Reduced 1.75%	1,323,661 $69.2 Million
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $6.25 Million - $7.11 Million	-150,439 Reduced 10.04%	1,347,271 $62.1 Million
Q3 2018 Nov 08, 2018	BUY	$46.76 - $51.24 $70 Million - $76.7 Million	1,497,710 New	1,497,710 $70.6 Million
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $3.99 Million - $4.54 Million	-90,113 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $1.84 Million - $2.21 Million	37,976 Added 72.84%	90,113 $4.44 Million
Q4 2017 Feb 13, 2018	BUY	$47.53 - $53.73 $2.48 Million - $2.8 Million	52,137	52,137 $2.8 Million

Others Institutions Holding NVO

# of Institutions

1,955

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $240B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Novo Nordisk A S Transaction History